0.00Open0.10Pre Close0 Volume6 Open Interest62.00Strike Price0.00Turnover7849.84%IV23.50%PremiumNov 29, 2024Expiry Date0.00Intrinsic Value100Multiplier-3DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type-0.0263Delta0.0064Gamma809.10Leverage Ratio-306.1199Theta0.0000Rho-21.28Eff Leverage0.0001Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet